rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
SUN PHARMACEUTICAL INDUSTRIES LTD. - Announces Q1 Results, Results Press Release and Limited Review Report for June 30, 2014
Download announcement < Back
13 Aug 2014
Sun Pharmaceutical Industries Ltd has announced the following results for the quarter ended June 30, 2014:&lt;br/&gt;&lt;br/&gt;The Unaudited results for the Quarter ended June 30, 2014&lt;br/&gt;&lt;br/&gt;The Company has posted a net profit of Rs. 475.60 million for the quarter ended June 30, 2014 where as the same was at Rs. 457.00 million for the quarter ended June 30, 2013. Total Income is Rs. 6597.90 million for the quarter ended June 30, 2014 where as the same was at Rs. 5825.40 million for the quarter ended June 30, 2013.&lt;br/&gt; &lt;br/&gt;The Consolidated Results are as follows :&lt;br/&gt;&lt;br/&gt;The Unaudited results for the Quarter ended June 30, 2014&lt;br/&gt; &lt;br/&gt;The Group has posted a Net Profit after taxes and minority interest of Rs. 13905.10 million for the quarter ended June 30, 2014 where as the Net (Loss) after taxes and minority interest for the quarter ended June 30, 2013 was at Rs. (12761.00) million. Total Income is Rs. 40279.60 million for the quarter ended June 30, 2014 where as the same was at Rs. 35775.60 million for the quarter ended June 30, 2013.&lt;br/&gt;&lt;br/&gt;&quot;Pursuant to the scheme of arrangement in the nature of demerger, the specified undertaking of Sun Pharma Global FZE. a wholly owned subsidiary, has been transferred into the Company w.e.f May 1, 2013, without any consideration, on a going concern basis consisting of all the assets and liabilities pertaining to the said undertaking. The scheme of arrangement has been approved by shareholders of both the companies and is also approved by the Honble High Court of Gujarat. Accordingly, the financial statements for the year ended March 31, 2014, earlier approved by the Board of Directors at their meeting held on May 29, 2014, have been revised and approved by them at their meeting held August 12, 2014. The effect of the Scheme was given in the financial results for the year ended March 31, 2014 only on an annual basis and approved by the Board of Directors at their meeting held on August 12, 2014. However, the financial results for quarterly periods during the year ended March 31, 2014 have not been restated in these results.&quot;&lt;br/&gt;
View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD. Source: BSE India